Silo Pharma, Inc. announced plans to submit an investigational new drug (IND) application for SPC-15, a novel intranasal treatment for Post-Traumatic Stress Disorder (PTSD), by the end of 2025, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback